Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Amorphizing Metal Selenides-Based ROS Biocatalysts at Surface Nanolayer toward Ultrafast Inflammatory Diabetic Wound Healing
Yuting Deng, Yang Gao, Tiantian Li, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2943-2957
Closed Access | Times Cited: 77
Engineering lactate-modulating nanomedicines for cancer therapy
Jiajie Chen, Yufang Zhu, Chengtie Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 973-1000
Closed Access | Times Cited: 46
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 21
A Near-Infrared-II Fluorescent Nanocatalyst for Enhanced CAR T Cell Therapy against Solid Tumor by Immune Reprogramming
Haimei Li, Xiuxiu Yang, Zichen Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 12, pp. 11749-11763
Closed Access | Times Cited: 26
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy
Qian Cheng, Xiao‐Lei Shi, Qilin Li, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 23
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 13
Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
Rou Yang, Lu Chen, Yiling Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 20
Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy
Zongquan Zhang, Xiaoya Liang, Xi Yang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6689-6708
Closed Access | Times Cited: 8
CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor
Wenjing Wu, Haimei Li, Wenqi Chen, et al.
Small (2024)
Closed Access | Times Cited: 5
2D Janus Carrier-Enabled Trojan Horse: Gallium Delivery for the Sequential Therapy of Biofilm Associated Infection
Zhaojiang Guo, Min Ge, Zesong Ruan, et al.
Biomaterials (2024) Vol. 313, pp. 122761-122761
Closed Access | Times Cited: 4
Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy
Xing Sun, Xican Xu, Fengying Li, et al.
Advanced Functional Materials (2025)
Closed Access
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications
Kehua Jiang, Hongming Liu, Xiaolong Chen, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4201-4234
Open Access
Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy
Hao Zhang, Yang Li, Mengxiao Han, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23001-23013
Closed Access | Times Cited: 3
Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Weizhi Chen, Cheng Li, Xiqun Jiang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 9
Advanced nanomaterials for enhanced immunotherapy via metabolic regulation
Xinyang Li, Binbin Ding, Pan Zheng, et al.
Coordination Chemistry Reviews (2023) Vol. 500, pp. 215540-215540
Closed Access | Times Cited: 8
Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism
Zhengying Gu, Chengzhong Yu
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Metabolic regulating enhanced immunological activating nanocomposites for tumor microenvironment normalization and immunotherapy
Chen Wang, Qiliner Feng, Hongli Lu, et al.
Materials Today Nano (2024) Vol. 27, pp. 100509-100509
Closed Access | Times Cited: 1
Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics
Asif Shahzad, Zhuoran Teng, Muhammad Arfat Yameen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117465-117465
Open Access | Times Cited: 1
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 1
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
Lulu Lv, Ruo han Huang, Jiale Li, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
Wei Qi, Lening Zhang, Nan Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
An Fe–Mn–S SOD-like nanozyme as an efficient antibacterial agent
Xiaowan Fan, Miaomiao Cheng, Saiyu Ma, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 22, pp. 10493-10496
Closed Access | Times Cited: 3
Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
Xiaojie Zhang, Min An, Juntao Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 241-257
Closed Access
Magnetic nanocarriers for cancer immunotherapy
Fatemeh Azizollahi, Hossein Kamali, Fatemeh Oroojalian
Elsevier eBooks (2024), pp. 349-401
Closed Access
Page 1 - Next Page

Scroll to top